Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DABIGATRAN for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 997 adverse event reports in the FDA FAERS database where DABIGATRAN was used for Atrial fibrillation.

Most Reported Side Effects for DABIGATRAN

Side Effect Reports % Deaths Hosp.
Gastrointestinal haemorrhage 210 10.1% 44 157
Hypotension 167 8.0% 11 139
Atrial fibrillation 150 7.2% 3 110
Drug interaction 143 6.9% 7 95
Haemorrhage 141 6.8% 21 84
Anaemia 131 6.3% 12 113
Dizziness 123 5.9% 6 97
Acute kidney injury 120 5.8% 14 99
Drug ineffective 118 5.7% 10 88
Fall 117 5.6% 3 97
Gastric haemorrhage 111 5.3% 0 94
Melaena 100 4.8% 5 90
Haematuria 85 4.1% 2 62
Cardiac failure 79 3.8% 7 65
Dyspnoea 76 3.7% 7 61

Other Indications for DABIGATRAN

Product used for unknown indication (478) Anticoagulant therapy (127) Deep vein thrombosis (58) Cerebrovascular accident prophylaxis (48) Pulmonary embolism (43) Cerebrovascular accident (35) Thrombosis prophylaxis (32) Prophylaxis (23) Atrial flutter (17) Embolism venous (13)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

DABIGATRAN Full Profile All Atrial fibrillation Drugs DABIGATRAN Demographics DABIGATRAN Timeline